The genetic or biological mechanisms underlying the inferior prognosis remain to be elucidated, but this may largely relate to the presence of hepatitis B X-interacting protein (HBXIP), which has been well-documented to function as an oncoprotein in breast cancer (33). Here, LAMTOR5 is linked to breast carcinoma.